BCMIO
PDLI

Beacon Capital Management Inc (Ohio)’s PDL BioPharma, Inc. PDLI Stock Holding History

Beacon Capital Management Inc (Ohio)’s Portfolio PDLI Stock Details PDLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-13
Closed – – 251
2017
Q1 		$0 Buy
+13
New +$29 ﹤0.01% 254
2015
Q2 		– Sell
-555
Closed -$4K – 269
2015
Q1 		$4K Buy
+555
New +$4.02K ﹤0.01% 206

Other funds holding PDLI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Beacon Capital Management Inc (Ohio)'s PDLI Position: Q2 2017 in Review

Beacon Capital Management Inc (Ohio) sold out of PDL BioPharma, Inc. (PDLI) in Q2 2017, closing a stake of 13 shares.

Beacon Capital Management Inc (Ohio) first reported a position in PDLI in Q1 2015 and held it in 2 quarters. The position peaked at $4K in Q1 2015. 171 funds tracked by Wall St. Rank hold PDLI as of Q2 2017.

  • Beacon Capital Management Inc (Ohio) reported no remaining PDL BioPharma, Inc. position as of Q2 2017 after selling out during the quarter.
  • Beacon Capital Management Inc (Ohio) sold 13 PDL BioPharma, Inc. shares in Q2 2017.
  • Beacon Capital Management Inc (Ohio) first reported a position in PDL BioPharma, Inc. in Q1 2015 and held it in 2 quarters.
  • Beacon Capital Management Inc (Ohio)'s PDL BioPharma, Inc. position peaked at $4K in Q1 2015.
  • 171 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q2 2017.

Based on Beacon Capital Management Inc (Ohio)'s 13F filing for Q2 2017, filed 11 Jul 2017.